Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal bevacizumab in acute branch retinal vein occlusion
IRCT201106214856N2Phase 2Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Mar 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bevacizumab in branch retinal vein occlusion (BRVO), sponsored by Baqiyatallah University of Medical Sciences. Started Mar 2011; status: completed.
02
Drugs
bevacizumab
03
Conditions
branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on IRCT201106214856N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201106214856N2.